| Dishman Carbogen Amcis Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540701 |
NSE Symbol : DCAL |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE385W01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 253.26 |
Market Cap(₹Cr) : 2,356.45 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 39.68 | 60.30 | 62.86 | 106.10 | 97.04 | 93.29 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 39.68 | 60.30 | 62.86 | 106.10 | 97.04 | 93.29 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 7.10 | 11.17 | 37.42 | 5.47 | -8.01 | 23.93 |
| Total Income | 46.78 | 71.47 | 100.28 | 111.57 | 89.03 | 117.22 |
| Total Expenditure | 43.18 | 55.89 | 59.43 | 85.57 | 74.08 | 79.89 |
| PBIDT | 3.60 | 15.58 | 40.85 | 26.00 | 14.95 | 37.33 |
| Interest | 23.51 | 20.61 | 20.26 | 21.31 | 17.77 | 15.59 |
| PBDT | -19.91 | -5.03 | 20.59 | 4.69 | -2.82 | 21.74 |
| Depreciation | 15.16 | 15.79 | 16.47 | 16.10 | 16.48 | 16.30 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -11.94 | -7.22 | 1.45 | -4.04 | -6.02 | -8.81 |
| Reported Profit After Tax | -23.13 | -13.60 | 2.67 | -7.37 | -13.28 | 14.25 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -23.13 | -13.60 | 2.67 | -7.37 | -13.28 | 14.25 |
| EPS (Unit Curr.) | -1.47 | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 |
| EPS (Adj) (Unit Curr.) | -1.47 | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 |
| Calculated EPS (Unit Curr.) | -1.48 | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 |
| Calculated EPS (Adj) (Unit Curr.) | -1.48 | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 |
| Calculated EPS (Ann.) (Unit Curr.) | -5.90 | -3.47 | 0.68 | -1.88 | -3.39 | 3.64 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -5.90 | -3.47 | 0.68 | -1.88 | -3.39 | 3.64 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 31.36 | 31.36 | 31.36 | 31.36 | 31.36 | 31.36 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.07 | 25.84 | 64.99 | 24.51 | 15.41 | 40.02 |
| PBDTM(%) | -50.18 | -8.34 | 32.76 | 4.42 | -2.91 | 23.30 |
| PATM(%) | -58.29 | -22.55 | 4.25 | -6.95 | -13.69 | 15.27 |
